Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 19 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
complex behaviours, including learning, in the small invertebrate model organism C. elegans. We have recently discovered a range of novel dopamine receptors in C. elegans and found that different receptors
-
researchers from around the world are tackling global issues and making a difference to people's lives. We believe that inspiring our people to do outstanding things at Durham enables Durham people to do
-
across the UK. IMPACT draws on knowledge gained from different types of research, the lived experience of people using services and their carers, and the practice knowledge of social care staff. Its aims
-
for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 19 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering different
-
of the Microverse” (www.microverse-cluster.de ), the CRC/Transregio 124 “Pathogenic Fungi and Their Human Host: Networks of Interaction” (www.funginet.de ) funded by the Deutsche Forschungsgemeinschaft and the
-
uncover how epithelial cells organise in space and time under different physico-chemical environments to drive self-organisation processes, like condensates, that shape mesoscale structures enabling tissue
-
research group, will be used for training. These data are available at different spatial resolutions, and the aim of the emulator is to downscale precipitation fields to an unprecedented resolution
-
aims at addressing computational challenges associated with data acquisition and information extraction from complex sensors and sensor networks. Crucially, uncertainty management and quantification
-
to biologic therapy (anti-thymicstomal lymphopoietin inhibition, TSLP) versus standard care and assess clinical remission and differences in clinical and biological outcomes after 48 weeks of therapy. About the